Skip to main content
Erschienen in: International Journal of Clinical Oncology 2/2013

01.04.2013 | Review Article

Randomized controlled trial versus comparative cohort study in verifying the therapeutic role of lymphadenectomy in endometrial cancer

verfasst von: Yukiharu Todo, Noriaki Sakuragi

Erschienen in: International Journal of Clinical Oncology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

A consensus regarding the therapeutic role of lymphadenectomy in endometrial cancer has not been reached because of conflicting negative results of randomized controlled trials and positive results of a cohort study. Since the effects of new treatments tend to be overestimated in observational studies, positive results of an observational study should be validated by a future trial. However, special difficulties are presented in randomized controlled trials in surgery. External validity is important for guaranteeing the reliability of a result of the trial. Physicians’ recruitment of eligible patients into a trial depends on the confidence of those physicians for a surgical procedure, workplace environment and feelings of personal responsibility relevant to patients’ risk of recurrence. When two surgical procedures are compared in a randomized controlled trial, technical quality control may be reduced in the complicated surgery group due to experienced surgeons’ non-participation. It is highly possible that the recruitment issue is a threat to external validity. Therefore, a randomized controlled trial may not be the best format for demonstrating the full benefits of complicated surgery. Multiple studies have demonstrated that the results of well-designed observational studies can be reliable and are comparable with those of randomized controlled trials. Journal editors and funding sources are requested to become more generous with observational studies, especially prospective cohort studies.
Literatur
1.
Zurück zum Zitat ASTEC study group (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 373:125–136CrossRef ASTEC study group (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 373:125–136CrossRef
2.
Zurück zum Zitat Benedetti-Panici P, Basile S et al (2008) Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707–1716PubMedCrossRef Benedetti-Panici P, Basile S et al (2008) Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707–1716PubMedCrossRef
3.
Zurück zum Zitat Black N (1996) Why we need observational studies to evaluate the effectiveness of health care. Br Med J 312:1215–1218CrossRef Black N (1996) Why we need observational studies to evaluate the effectiveness of health care. Br Med J 312:1215–1218CrossRef
4.
Zurück zum Zitat Rothwell PM (2005) External validity of randomized controlled trials: “To whom do the results of this trial apply?”. Lancet 365:382–393 Rothwell PM (2005) External validity of randomized controlled trials: “To whom do the results of this trial apply?”. Lancet 365:382–393
5.
Zurück zum Zitat Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342:1878–1886PubMedCrossRef Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342:1878–1886PubMedCrossRef
6.
Zurück zum Zitat Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887–1892PubMedCrossRef Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887–1892PubMedCrossRef
7.
Zurück zum Zitat Burke TW, Levenback C, Tornos C et al (1996) Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in woman with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 62:169–173PubMedCrossRef Burke TW, Levenback C, Tornos C et al (1996) Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in woman with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 62:169–173PubMedCrossRef
8.
Zurück zum Zitat Hirahatake K, Hareyama H, Sakuragi N et al (1997) A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol 65:82–87PubMedCrossRef Hirahatake K, Hareyama H, Sakuragi N et al (1997) A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol 65:82–87PubMedCrossRef
9.
Zurück zum Zitat Mariani A, Dowdy SC, Cliby WA et al (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109:111–118CrossRef Mariani A, Dowdy SC, Cliby WA et al (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109:111–118CrossRef
10.
Zurück zum Zitat Matsumoto K, Yoshikawa H, Yasugi T et al (2002) Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas. Cancer Lett 180:83–89PubMedCrossRef Matsumoto K, Yoshikawa H, Yasugi T et al (2002) Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas. Cancer Lett 180:83–89PubMedCrossRef
11.
Zurück zum Zitat Todo Y, Kato H, Kaneuchi M et al (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL Study): a retrospective cohort analysis. Lancet 375:1165–1172PubMedCrossRef Todo Y, Kato H, Kaneuchi M et al (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL Study): a retrospective cohort analysis. Lancet 375:1165–1172PubMedCrossRef
12.
Zurück zum Zitat Horwitz RI (1987) Complexity and contradiction in clinical trial research. Am J Med 82:498–510PubMedCrossRef Horwitz RI (1987) Complexity and contradiction in clinical trial research. Am J Med 82:498–510PubMedCrossRef
13.
Zurück zum Zitat Chalmers TC, Celano P, Sacks HS et al (1983) Bias in treatment assignment in controlled clinical trials. N Engl J Med 309:1358–1361PubMedCrossRef Chalmers TC, Celano P, Sacks HS et al (1983) Bias in treatment assignment in controlled clinical trials. N Engl J Med 309:1358–1361PubMedCrossRef
14.
Zurück zum Zitat Kunz R, Oxman AD (1998) The unpredictability paradox: review of empirical comparisons of randomized and non-randomised clinical trials. Br Med J 317:1185–1190CrossRef Kunz R, Oxman AD (1998) The unpredictability paradox: review of empirical comparisons of randomized and non-randomised clinical trials. Br Med J 317:1185–1190CrossRef
15.
Zurück zum Zitat Lawrie GM, Morris GC Jr, Howell JF et al (1977) Special correspondence: a debate on coronary bypass. N Engl J Med 297:1464–1470CrossRef Lawrie GM, Morris GC Jr, Howell JF et al (1977) Special correspondence: a debate on coronary bypass. N Engl J Med 297:1464–1470CrossRef
16.
Zurück zum Zitat McLeod RS (1999) Issues in surgical randomized controlled trials. World J Surg 23:1210–1214PubMedCrossRef McLeod RS (1999) Issues in surgical randomized controlled trials. World J Surg 23:1210–1214PubMedCrossRef
17.
Zurück zum Zitat Colombo N, Preti E, Landoni F et al (2011) Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 22:35–39CrossRef Colombo N, Preti E, Landoni F et al (2011) Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 22:35–39CrossRef
18.
Zurück zum Zitat King SB 3rd, Lembo NJ, Weintraub WS et al (1994) A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med 331:1044–1050PubMedCrossRef King SB 3rd, Lembo NJ, Weintraub WS et al (1994) A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med 331:1044–1050PubMedCrossRef
19.
Zurück zum Zitat King SB 3rd, Barnhart HX, Kosinski AS et al (1997) Angioplasty or surgery for multivessel coronary artery disease: comparing of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. Am J Cardiol 79:1453–1459PubMedCrossRef King SB 3rd, Barnhart HX, Kosinski AS et al (1997) Angioplasty or surgery for multivessel coronary artery disease: comparing of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. Am J Cardiol 79:1453–1459PubMedCrossRef
20.
Zurück zum Zitat Rubin DB (1997) Estimating causal effects from large data sets using propensity score. Ann Intern Med 127:757–763PubMed Rubin DB (1997) Estimating causal effects from large data sets using propensity score. Ann Intern Med 127:757–763PubMed
21.
Zurück zum Zitat Solomon MJ, McLeod RS (1993) Clinical studies in surgical journals—have we improved? Dis Colon Rectum 36:43–48PubMedCrossRef Solomon MJ, McLeod RS (1993) Clinical studies in surgical journals—have we improved? Dis Colon Rectum 36:43–48PubMedCrossRef
22.
Zurück zum Zitat Allen PJ, Stojadinovic A, Shriver CD et al (1998) Contributions from surgeons to clinical trials and research on the management of soft tissue sarcoma. Ann Surg Oncol 5:437–441PubMedCrossRef Allen PJ, Stojadinovic A, Shriver CD et al (1998) Contributions from surgeons to clinical trials and research on the management of soft tissue sarcoma. Ann Surg Oncol 5:437–441PubMedCrossRef
23.
Zurück zum Zitat Klabunde CN, Springer BC, Butler B et al (1999) Factors influencing enrollment in clinical trials for cancer treatment. South Med J 92:1189–1193PubMedCrossRef Klabunde CN, Springer BC, Butler B et al (1999) Factors influencing enrollment in clinical trials for cancer treatment. South Med J 92:1189–1193PubMedCrossRef
24.
Zurück zum Zitat Solomon MJ, Laxamana A, Devore L et al (1994) Randomized controlled trials in surgery. Surgery 115:707–712PubMed Solomon MJ, Laxamana A, Devore L et al (1994) Randomized controlled trials in surgery. Surgery 115:707–712PubMed
25.
Zurück zum Zitat Ross S, Grant A, Counsell C et al (1999) Barriers to participation in randomized controlled trials: a systematic review. J Clin Epidemiol 52:1143–1156PubMedCrossRef Ross S, Grant A, Counsell C et al (1999) Barriers to participation in randomized controlled trials: a systematic review. J Clin Epidemiol 52:1143–1156PubMedCrossRef
26.
Zurück zum Zitat Abraham NS, Hewett P, Young JM et al (2006) Non-entry of eligible patients into the Australasian Laparoscopic Colon Cancer study. ANZ Surg 76:825–829CrossRef Abraham NS, Hewett P, Young JM et al (2006) Non-entry of eligible patients into the Australasian Laparoscopic Colon Cancer study. ANZ Surg 76:825–829CrossRef
27.
Zurück zum Zitat Jenkins V, Fallowfield L (2000) Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer 82:1783–1788PubMedCrossRef Jenkins V, Fallowfield L (2000) Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer 82:1783–1788PubMedCrossRef
28.
Zurück zum Zitat Harrison JD, Solomon MJ, Young JM et al (2007) Surgical and oncology trials for rectal cancer: who will participate? Surgery 142:94–101PubMedCrossRef Harrison JD, Solomon MJ, Young JM et al (2007) Surgical and oncology trials for rectal cancer: who will participate? Surgery 142:94–101PubMedCrossRef
29.
Zurück zum Zitat Cox K, McGarry J (2003) Why patients don’t take part in cancer clinical trials: an overview of the literature. Eur J Cancer Care 12:114–122CrossRef Cox K, McGarry J (2003) Why patients don’t take part in cancer clinical trials: an overview of the literature. Eur J Cancer Care 12:114–122CrossRef
30.
Zurück zum Zitat Chang RW, Falconer J, Stulberg SD et al (1990) Prerandomization: an alternative to classic randomization. The effects on recruitment in a controlled trial of arthroscopy for osteoarthrosis of the knee. J Bone Joint Surg Am 72:1451–1455PubMed Chang RW, Falconer J, Stulberg SD et al (1990) Prerandomization: an alternative to classic randomization. The effects on recruitment in a controlled trial of arthroscopy for osteoarthrosis of the knee. J Bone Joint Surg Am 72:1451–1455PubMed
31.
Zurück zum Zitat Taylor KM, Margolese RG, Soskolne CL (1984) Physicians’ reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med 310:1363–1367PubMedCrossRef Taylor KM, Margolese RG, Soskolne CL (1984) Physicians’ reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med 310:1363–1367PubMedCrossRef
32.
Zurück zum Zitat Solomon MJ, Pager CK, Young JM et al (2003) Patient entry into randomized controlled trials of colorectal cancer treatment: factors influencing participation. Surgery 133:608–613PubMedCrossRef Solomon MJ, Pager CK, Young JM et al (2003) Patient entry into randomized controlled trials of colorectal cancer treatment: factors influencing participation. Surgery 133:608–613PubMedCrossRef
33.
Zurück zum Zitat Benson AB 3rd, Pregler JP, Bean JA et al (1991) Oncologists’ reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. J Clin Oncol 9:2067–2075PubMed Benson AB 3rd, Pregler JP, Bean JA et al (1991) Oncologists’ reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. J Clin Oncol 9:2067–2075PubMed
34.
Zurück zum Zitat Taylor KM (1992) Physician participation in a randomized clinical trial for ocular melanoma. Ann Ophthalmol 24:337–344PubMed Taylor KM (1992) Physician participation in a randomized clinical trial for ocular melanoma. Ann Ophthalmol 24:337–344PubMed
35.
Zurück zum Zitat Penn ZJ, Steer PJ (1990) Reasons for declining participation in a prospective randomized trial to determine the optimum mode of delivery of the preterm breech. Control Clin Trials 11:226–231PubMedCrossRef Penn ZJ, Steer PJ (1990) Reasons for declining participation in a prospective randomized trial to determine the optimum mode of delivery of the preterm breech. Control Clin Trials 11:226–231PubMedCrossRef
36.
Zurück zum Zitat Ellis PM (2000) Attitudes towards and participation in randomized clinical trials in oncology: a review of the literature. Ann Oncol 11:939–945PubMedCrossRef Ellis PM (2000) Attitudes towards and participation in randomized clinical trials in oncology: a review of the literature. Ann Oncol 11:939–945PubMedCrossRef
37.
Zurück zum Zitat Albrecht TL, Blanchard C, Ruckdeschel JC et al (1999) Strategic physician communication and oncology clinical trials. J Clin Oncol 17:3324–3332PubMed Albrecht TL, Blanchard C, Ruckdeschel JC et al (1999) Strategic physician communication and oncology clinical trials. J Clin Oncol 17:3324–3332PubMed
38.
Zurück zum Zitat McCulloch P, Taylor I, Sasako M et al (2002) Randomised trials in surgery: problems and possible solutions. Br Med J 324:1448–1451CrossRef McCulloch P, Taylor I, Sasako M et al (2002) Randomised trials in surgery: problems and possible solutions. Br Med J 324:1448–1451CrossRef
39.
Zurück zum Zitat Kapiteijn E, Kranenbarg EK, Steup WH et al (1999) Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomized trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group. Eur J Surg 165:410–420PubMedCrossRef Kapiteijn E, Kranenbarg EK, Steup WH et al (1999) Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomized trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group. Eur J Surg 165:410–420PubMedCrossRef
40.
Zurück zum Zitat van der Linden W (1980) Pitfalls in randomized surgical trials. Surgery 87:258–262PubMed van der Linden W (1980) Pitfalls in randomized surgical trials. Surgery 87:258–262PubMed
41.
Zurück zum Zitat Sacks H, Chalmers TC, Smith H Jr (1982) Randomized versus historical controls for clinical trials. Am J Med 72:233–240PubMedCrossRef Sacks H, Chalmers TC, Smith H Jr (1982) Randomized versus historical controls for clinical trials. Am J Med 72:233–240PubMedCrossRef
42.
Zurück zum Zitat Colditz GA, Miller JN, Mosteller F (1989) How study design affects outcomes in comparisons of therapy. I: medial. Stat Med 8:441–454PubMedCrossRef Colditz GA, Miller JN, Mosteller F (1989) How study design affects outcomes in comparisons of therapy. I: medial. Stat Med 8:441–454PubMedCrossRef
43.
Zurück zum Zitat Miller JN, Colditz GA, Mosteller F (1989) How study design affects outcomes in comparisons of therapy. II: surgical. Stat Med 8:455–466PubMedCrossRef Miller JN, Colditz GA, Mosteller F (1989) How study design affects outcomes in comparisons of therapy. II: surgical. Stat Med 8:455–466PubMedCrossRef
44.
Zurück zum Zitat McKee M, Britton A, Black N et al (1999) Methods in health service research. Interpreting the evidence: choosing between randomized and non-randomised studies. BMJ 319:312–315PubMedCrossRef McKee M, Britton A, Black N et al (1999) Methods in health service research. Interpreting the evidence: choosing between randomized and non-randomised studies. BMJ 319:312–315PubMedCrossRef
45.
Zurück zum Zitat Abraham NS, Byrne CJ, Young JM et al (2010) Meta-analysis of well-designed nonrandomized comparative studies of surgical procedures is as good as randomized controlled trials. J Clin Epidemiol 63:238–245PubMedCrossRef Abraham NS, Byrne CJ, Young JM et al (2010) Meta-analysis of well-designed nonrandomized comparative studies of surgical procedures is as good as randomized controlled trials. J Clin Epidemiol 63:238–245PubMedCrossRef
Metadaten
Titel
Randomized controlled trial versus comparative cohort study in verifying the therapeutic role of lymphadenectomy in endometrial cancer
verfasst von
Yukiharu Todo
Noriaki Sakuragi
Publikationsdatum
01.04.2013
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 2/2013
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-012-0499-0

Weitere Artikel der Ausgabe 2/2013

International Journal of Clinical Oncology 2/2013 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.